Ruutu, Tapani http://orcid.org/0000-0002-4010-8345
Peczynski, Christophe http://orcid.org/0000-0002-3829-0088
Houhou, Mohamed
Polge, Emmanuelle
Mohty, Mohamad http://orcid.org/0000-0002-7264-808X
Kröger, Nicolaus http://orcid.org/0000-0001-5103-9966
Moiseev, Ivan http://orcid.org/0000-0002-4332-0114
Penack, Olaf http://orcid.org/0000-0003-4876-802X
Salooja, Nina http://orcid.org/0000-0001-5668-9001
Schoemans, Hélène http://orcid.org/0000-0002-7568-8239
Duarte, Rafael F.
Schroeder, Thomas
Passweg, Jakob
Wulf, Gerald G.
Ganser, Arnold
Sica, Simona
Arat, Mutlu http://orcid.org/0000-0003-2039-8557
Salmenniemi, Urpu
Broers, Annoek E. C.
Bourhis, Jean Henri
Rambaldi, Alessandro
Maertens, Johan http://orcid.org/0000-0003-4257-5980
Halaburda, Kazimierz
Zuckerman, Tsila http://orcid.org/0000-0002-6204-977X
Labussière-Wallet, Hélène
Basak, Grzegorz http://orcid.org/0000-0003-3858-8180
Koenecke, Christian http://orcid.org/0000-0001-7025-1735
Perić, Zinaida http://orcid.org/0000-0001-9458-8025
Article History
Received: 28 February 2023
Revised: 12 July 2023
Accepted: 26 July 2023
First Online: 12 August 2023
Competing interests
: MM received research support and honoraria for lectures from Amgen, Astellas, BMS, GSK, Janssen, Jazz Pharmaceuticals, Pfizer, Takeda, Oncopeptides, Adaptive, and Sanofi. NK served as consultant and received honoraria from Jazz Pharmaceuticals. OP received research and travel support and served as a member of advisory board of Jazz Pharmaceuticals. HS reports having received personal fees from Incyte, Janssen, Novartis, Sanofi and from the Belgian Hematological Society (BHS), as well as research grants from Novartis and the BHS, both paid to her institution. She has received non-financial support from Gilead, Pfizer, the EBMT (European Society for Blood and Marrow Transplantation) and the CIBMTR (Center for International Bone Marrow Transplantation Research). She has also frequently served as a volunteer for EBMT, CIBMTR and EUPATI. RFD received honoraria as speaker for Jazz Pharmaceuticals. TR, IM, TS, JHB, AR, and GB received honoraria from Jazz Pharmaceuticals. CP, MH, EP, NS, JP, GGW, AG, SS, MA, US, AECB, JM, KH, TZ, HL-W, CK, and ZP declare no competing interests.